首页/数据集/Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)

Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)

NCATS Open Data2021-12-24 更新2026-08-08 收录

抗体中和效力

奥密克戎变异株免疫逃逸

数据链接：

https://doi.org/10.1101/2021.12.19.473354 数据链接链接失效反馈

官方服务：

资源简介：

Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)

应用场景：

创建时间：

2021-12-20

抗体中和效力

毒素防护实验

Neutralization potencies of hu8BLC3 and hu8B2-7, tested individually or in combination, against 5 MLD50 of BoNT/B2 in complex form. The preparations of antibodies and toxin (0.5 mL) were injected intr

NIAID Data Ecosystem80

IC50 values of scFv-Fc A7 with a panel of tier 1 and tier 2 pseudoviruses in neutralization assay on tzm-bl cells.

抗体中和效力

假病毒中和实验

IC50 values of scFv-Fc A7 with a panel of tier 1 and tier 2 pseudoviruses in neutralization assay on tzm-bl cells.

NIAID Data Ecosystem60

Neutralisation potencies of wild type VHH 2E7 and mutated variants in TZM-b1 neutralisation assay.

抗体中和效力

病毒中和实验

Comparison of neutralization potencies of VHH 2E7 wild type and 5 mutants against a panel of 4 viruses. IC50 values are given in µg/mL. Not done is marked as Nd.

Figshare2015-12-02 更新50

Human Cytomegalovirus Vaccine Based on the Envelope gH/gL Pentamer Complex

病毒疫苗开发

抗体中和效力

Human Cytomegalovirus (HCMV) utilizes two different pathways for host cell entry. HCMV entry into fibroblasts requires glycoproteins gB and gH/gL, whereas HCMV entry into epithelial and endothelial ce

NIAID Data Ecosystem80

SARS-CoV-2 BA.1 and BA.2 breakthrough infections boost antibody responses to early Omicron subvariants but not BQ.1.1 and XBB.1.5

病毒免疫应答

抗体中和效力

Here, the authors describe the potency and breadth of neutralizing and binding antibody responses against a large panel of VOC following an Omicron BA.1 or BA.2 breakthrough infection.

NIAID Data Ecosystem60

Variable loss of antibody potency against SARS-CoV-2 B.1.1.529 (Omicron)

资源简介：

相关数据集